PLI Scheme Boosts Manufacturing

Electronics Manufacturing Receives Bulk of Incentive Payouts

Large-scale electronics production took the lion's share of PLI funds, accounting for ₹19,090.98 crore out of the total ₹36,754 crore disbursed. The sector's funding has accelerated sharply: ₹10,114 crore in fiscal 2024–25 jumped to ₹15,519 crore in 2025–26, with ₹1,400 crore already distributed in the first quarter of this fiscal year, Moneycontrol noted.

1 source

Pharma Sector Builds New Drug Manufacturing Capacity

The pharmaceutical industry has generated cumulative sales exceeding ₹3.64 lakh crore under the PLI scheme. Companies have manufactured 1,931 new pharmaceutical products and developed domestic production of critical bulk drugs that were previously imported. Financial Express reported that pharma PLI investments reached ₹46,744 crore—nearly 2.7 times the target—as of June 2026.

These gains have reduced India's dependence on foreign pharmaceutical imports, a key goal of the scheme. TenNews highlighted how the program has strengthened the nation's bulk drugs and API manufacturing ecosystem.

2 sources

Medical Devices Get New Domestic Production Lines

India's medical device sector benefited from technology-transfer partnerships with global companies. Siemens, Wipro GE and Philips supported domestic production of CT/MRI systems, catheterisation labs and ultrasound equipment. PLI beneficiaries reported ₹6,475 crore in domestic sales, ₹560 crore in exports and ₹1,400 crore in implant revenue.

Specialty Steel Companies Invest Over ₹19,000 Crore

India's specialty steel sector saw major capital commitments from leading manufacturers. JSW, Jindal Odisha, Tata Steel and AMNS invested more than ₹19,000 crore combined under the PLI scheme. These investments have expanded India's capacity to produce advanced specialty steel grades domestically rather than relying on imports.